NCT00365157 2025-07-11Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney DysfunctionNational Cancer Institute (NCI)Phase 1/2 Active not recruiting132 enrolled